As of today (2025-05-03), the Forward Annual Dividend Yield of 10x Genomics is 0.00%.
As of today (2025-05-03), the Trailing Annual Dividend Yield of 10x Genomics is 0.00%.
TXG's Forward Dividend Yield % is not ranked *
in the Healthcare Providers & Services industry.
Industry Median: 2.45 * Ranked among companies with meaningful Forward Dividend Yield % only.
The growth rate is calculated with least square regression.
For more information regarding to dividend, please check our Dividend Page.
Competitive Comparison of 10x Genomics's Forward Dividend Yield %
For the Health Information Services subindustry, 10x Genomics's Forward Dividend Yield %, along with its competitors' market caps and Forward Dividend Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
10x Genomics's Forward Dividend Yield % Distribution in the Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, 10x Genomics's Forward Dividend Yield % distribution charts can be found below:
* The bar in red indicates where 10x Genomics's Forward Dividend Yield % falls into.
Over the long term, the return from dividends has been a significant contributor to the total returns produced by equity securities. Studies by Elroy Dimson, Paul Marsh, and Mike Staunton of Princeton University (2002) found that a market-oriented portfolio, which included reinvested dividends, would have generated nearly 85 times the wealth generated by the same portfolio relying solely on capital gains.
Dividends may also qualify a lower tax rate for investors.
In dividends investing, Payout Ratio and Dividend Growth Rate are the two most important variables for consideration. A lower payout ratio may indicate that the company has more room to increase its dividends.
10x Genomics Forward Dividend Yield % Related Terms
Thank you for viewing the detailed overview of 10x Genomics's Forward Dividend Yield % provided by GuruFocus.com. Please click on the following links to see related term pages.
10x Genomics Inc is a life science technology company based in the United States. Its solutions include instruments, consumables, and software for analyzing biological systems. The company's integrated solutions include instruments, consumables, and software for analyzing biological systems at a resolution and scale that matches the complexity of biology. Its product offerings include a Chromium platform comprising microfluidic chips and related consumables, Chromium X series, Visium and Xenium platforms, and others, which are predominantly used for the study of biological components. Geographically, the company derives maximum revenue from the United States and the rest from Americas (excluding the United States), Europe, Middle East and Africa, China, and Asia-Pacific (excluding China).
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
TXG has been successfully added to your